Table 2 from Immune Activation Signatures Associated with Fatigue in Cancer Patients Undergoing Immune Checkpoint Inhibitor Therapy

This is a Quantitative Study study.

Key Points

Patients with ICI-related fatigue showed differing responses to therapy compared to those without fatigue, indicating a relationship.
Best therapy response differed significantly between patients experiencing fatigue and those who did not, which is crucial for treatment strategies.
The research assessed immune activation signatures, providing insights for managing ICI-related fatigue in cancer care.
Understanding these variations may enhance treatment approaches for cancer patients undergoing immune checkpoint inhibitor therapy.

Analysis shows varying therapy responses in cancer patients, highlighting immune activation signatures tied to fatigue.

Best response to therapy in patients with ICI-related fatigue versus those without ICI-related fatigue.

No takes yet. Share an insight, caveat, or question.

Li et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Share